Asclepion MCL31 Dermablate

The MCL 31 Dermablate is a pulsed Er:YAG laser from Asclepion Laser Technologies in Jena, Germany, emitting at 2940 nm. It is the middle step in a long line of Dermablate systems. The FDA cleared an MCL 30 Dermablate in 2004 and a Dermablate Effect in 2009, then the MCL 31 under K150140 in June 2015. In July 2024 the FDA cleared a modified successor under K241600, sold simply as Dermablate.

The 2015 filing describes a main console, a handpiece, a footswitch and a built in suction unit that removes laser plume at the treatment site. It lists 2.5 J maximum pulse energy, 20 W maximum power, up to 20 Hz, spots from 1 to 12 mm and pulse widths of 100 to 1,000 microseconds. The Dermablate Effect before it was limited to 1.5 J, 12 W, spots of 1 to 6 mm and a 350 microsecond pulse. Asclepion added a fractional MicroSpot handpiece under K152153 in December 2015, and a MY JULIET microbeam handpiece under K210634 in April 2022. The cleared uses cover coagulation, vaporization, ablation or cutting of skin across dermatology, plastic surgery, ENT, gynecology, oral surgery, general surgery, podiatry and skin around the eyes.

Sellers often confuse the MCL 31 with the current Dermablate. The 2024 model raises maximum energy to 3 J and adds a DeepSpot fractional handpiece, and Asclepion's current brochure lists a pulse range up to 1,500 microseconds. If the label reads MCL 31 and the console tops out at 2.5 J, it is the earlier model. Check the label rather than the screen logo, because both carry the Dermablate name.

List each handpiece by name, since the VarioTEAM, MicroSpot and MY JULIET handpieces were cleared at different times. A buyer will ask about the flashlamp, the pulse counter, the suction unit and its filters, and the condition of the handpiece lenses. Photograph the serial label, the energy settings screen and every handpiece.